Etiqueta: latin america
Report: COVID-19 vaccines in Latin America
Regulatory agencies in Latin America continue to march ahead with COVID-19 vaccine approvals. Mexico’s COFEPRIS got the ball rolling when it authorised emergency use of Pfizer/BioNTech’s Comirnaty in mid-December. Argentina’s ANMAT was first with the AZ/Oxford vaccine.
As COVID-19 vaccination drives continue to get underway globally, the major regulatory agencies...
Megalabs brings cannabidiol to Latam
Regulations on the use of treatments based on cannabidiol vary across the region. In Argentina, the use of medicinal oil must be requsted under "compassionate use". But a major Latin American player has become the representative of a US firm specialising in medicinal cannabis.
The major Latin American multinational...
US drugmaker in local COVID-19 quarantine
English version
The effects of the global coronavirus pandemic have reached Argentina. Most drugmakers are cancelling congresses, conventions and international meetings.
The staff of US drugmaker Biogen's Argentina office are working from home in quarantine after several company executives tested positive for COVID-19.
US media reports cite three leaders testing positive in...
Sidus seals deal with Lifescan
English version
From April 1. Argentine drugmaker Sidus will be the commercial representative of the LifeScan line of blood glucose monitors in Argentina. The brand, which belongs to the private investment firm Platinum Equity has been licensed to firm owned by the Argüelles family and will have no connection with...
Megalabs snaps up GSK brands
English version
The Consumer Health sector is seeing continual reorganisation internationally. Joining the list of pharma multinationals who've bought assets only to sell them on not long afterwards is GSK. The drugmaker has offloaded a trio of mature brands in the Latin America region into the hands of the regional...
Takeda sells 18 brands
English version
Since Japan's Takeda acquired Shire in 2018, the drugmaker's course towards a specialist focus has been set. The sale of its portfolio of mature drugs has been predicted. Two local brands have changed hands for now as part of a deal with regional reach.
Japan's Takeda has sold...
Roemmers buys Bactrim Latam
English version
The Roemmers group has sealed another deal with Swiss drugmaker Roche. It had already bought the company's primary care package in Argentina and now takes on Bactrim and Dormicum for the wider Latam region. Pharmabiz has been told the deal totalled around US$ 75 million.
Argentine group Roemmers, which bought out Swiss drugmaker Roche's package of primary care products on the local...
CASIC en In-cosmetics, Latam
La CASIC, la entidad que nuclea a las cámaras de cosmética de la región, formó parte de la feria anual In-cosmetics. El evento se llevó a cabo la semana pasada en el estado de San Pablo, en Brasil.
La quinta edición anual de la feria In-cosmetics se llevó a cabo la semana...
Valsartan measures in Latam
English version
The international recall of valsartan is directly impacting the cardio segment in Latin America. After the EMA made the first move and the FDA also stepped in, Pharmabiz analyzes the position of the Latin American regulators.
The region's regulators have acted following the EMA's July 5 announcement of the revision of medicines based on valsartan manufactured with defective raw materials.
Colombia,...
KPMG gets its data in a twist in Argentina
English version
International consultation and auditing company KPMG is getting its data in a twist in Argentina, at least in the Pharma sector.
International consultation and auditing company KPMG, one of the four giants on the global stage alongside Deloitte, PWC and Ernst & Young is getting its data in a twist in Argentina, at least in the Pharma...
Indian drugmakers focus on Latin America
English Version
India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru.
India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru.
In Argentina, inroads had been made during the previous government’s administration, led by Cristina Fernández...
Bayer event: focus on Latin America
English Version
Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for the continent and detail its performance in each country.
Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for...
Eurofarma buys Sanofi Argentine plant
English Version
Brazilian firm Eurofarma has bought Sanofi’s plant in Lomas del Mirador, Argentina. The decision comes after a long process of due diligence in which the company, overseen by Mauricio Billi, looked closely at its figures.
Brazilian firm Eurofarma has bought Sanofi’s plant in Argentina. The decision comes after a long process of due diligence in which the company, overseen...
Murray: global pharma perspectives
New Zealander Murray Aitken, Executive Director of IMS Institute for Healthcare Informatics, arrived in Argentina to give his global perspectives.
English Version
New Zealander Murray Aitken –Executive Director of IMS Institute for Healthcare Informatics- arrived in Argentina to give his global perspectives.
Aitken explained which therapeutic areas were the most important and grew at the fastest...
IMS World Review: emerging countries, prices and more
The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event had a special flavour this year because IMS is celebrating 40 years in Argentina.
English version
The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event...